ABP Adolescent flashcards
ABP Adolescent · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Tanner stage B2
- Breast bud stage in girls: areola widens and breast tissue emerges; typically the first visible sign of puberty, average onset ages 9-11.
- First sign of male puberty
- Testicular enlargement to at least 4 mL is usually the first sign of puberty in boys, typically between ages 9.5 and 14.
- Precocious puberty thresholds
- Puberty before age 8 in girls or age 9 in boys; evaluate for central or peripheral causes with GnRH stimulation and bone age.
- Delayed puberty definition
- Absence of breast development by age 13 in girls or testicular enlargement by age 14 in boys, or puberty taking more than five years to complete.
- Peak height velocity
- Maximum growth rate during puberty: about 9 cm/year in girls and 10.5 cm/year in boys; boys' spurt occurs later, around Tanner 3-4.
- Menarche timing
- First menstrual period, typically 2 to 2.5 years after thelarche and around age 12-12.5; growth slows after menarche.
- Mid-parental height
- For boys: (father's height + mother's height + 13 cm)/2; for girls: (father's height + mother's height − 13 cm)/2; ±8.5 cm range.
- HPV vaccine schedule
- Routine at 11-12 years; two doses if started before 15th birthday (0, 6-12 months); three doses if started at 15 or older.
- Tdap and MenACWY
- Tdap and meningococcal ACWY booster at 11-12 years; MenACWY booster at 16; MenB shared decision at 16-18.
- HEEADSSS assessment
- Psychosocial interview covering Home, Education, Eating, Activities, Drugs, Sexuality, Suicide/depression, and Safety; used at adolescent preventive visits.
- USPSTF depression screening
- Screen adolescents aged 12-18 for major depressive disorder; the USPSTF also recommends anxiety screening for ages 8-18.
- Chlamydia screening
- Annual chlamydia and gonorrhea screening for sexually active females aged 24 or younger; also screen males in high-prevalence settings.
- Lipid screening in adolescents
- AAP recommends one lipid panel between ages 9-11 and again between 17-21; earlier if risk factors such as obesity or family history.
- Minor confidentiality
- Adolescents may consent to confidential care for STIs, contraception, and mental health in many jurisdictions; explain limits such as imminent danger.
- PHQ-A depression screen
- Adolescent PHQ-9; score of 10 or more suggests moderate depression; item 9 assesses suicidal ideation and requires immediate follow-up.
- First-line adolescent depression
- Fluoxetine is approved for ages 8 and older; escitalopram for ages 12 and older; combine with cognitive behavioral therapy.
- Suicide risk screening
- Ask directly about thoughts, plans, intent, and access to lethal means; positive screens need same-day safety assessment and means counseling.
- ADHD diagnostic criteria
- DSM-5 requires symptoms before age 12, in two or more settings, causing impairment; stimulants are first-line medication after cardiac history review.
- Anorexia nervosa criteria
- Restriction causing low weight, intense fear of weight gain, and body image disturbance; amenorrhea is no longer required in DSM-5.
- CRAFFT screening
- Six-item substance use screen for adolescents; score of 2 or more indicates high risk and warrants brief intervention or further assessment.
- Delayed sleep phase
- Adolescent circadian shift causes late sleep onset; treatment includes fixed wake time, morning light, and limited evening screens.
- LARC first-line
- Long-acting reversible contraception, including implants and intrauterine devices, is recommended first-line for adolescents because it is highly effective.
- Emergency contraception timing
- Levonorgestrel works best within 72 hours; ulipristal within 120 hours; copper IUD can be placed within 5 days for emergency contraception.
- Chlamydia treatment
- Doxycycline 100 mg twice daily for 7 days is first-line for chlamydia in adolescents; azithromycin is no longer preferred due to resistance.
- Gonorrhea treatment
- Ceftriaxone 500 mg intramuscularly once for patients under 150 kg; add doxycycline if chlamydia is not excluded.
- Condom counseling
- External condoms reduce STI and pregnancy risk; advise consistent use with every act and offer dual protection with a long-acting method.
- HPV and STI prevention
- HPV vaccination prevents most cervical and anogenital cancers; screen sexually active adolescents for STIs regardless of vaccination status.
- Asthma step therapy
- Use inhaled corticosteroids as controller for persistent asthma; short-acting beta agonist as reliever; step up or down based on control.
- Diabetic ketoacidosis signs
- Polyuria, polydipsia, weight loss, nausea, abdominal pain, Kussmaul breathing, and fruity breath; check glucose and ketones urgently.
- E-cigarette counseling
- Vaping nicotine is common in adolescents and causes dependence; screen at every visit and offer cessation counseling and nicotine replacement when appropriate.
- Opioid overdose response
- Give naloxone intranasally or intramuscularly for suspected overdose; call emergency services and support breathing until help arrives.
- Concussion return to learn
- Cognitive rest followed by gradual return to school; return to sports only after symptoms resolve and a stepwise protocol is completed.